EDITORIAL COMMENT   Free access

Minerva Urology and Nephrology 2021 October;73(5):677-9

DOI: 10.23736/S2724-6051.21.04724-8

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Comment on: “Predictive factors for opioid-free management after robotic radical prostatectomy: the value of a single-port robotic platform”

Stefano PULIATTI ^{1, 2}, Pietro PIAZZA ^{2, 3}, Giovanni E. CACCIAMANI ⁴, Juan GÓMEZ RIVAS ⁵, Mark TARATKIN ⁶, José L. MARENCO ⁷, Ines RIVERO BELENCHON ⁸, Karl-Friedrich KOWALEWSKI ⁹, Enrico CHECCUCCI ^{10, 11} ✉, on behalf of the Uro-Technology and SoMe Working Group of the Young Academic Urologists Working Party of the European Association of Urology

¹ Department of Urology, University of Modena and Reggio Emilia, Modena, Italy; ² Orsi Academy, Ghent, Belgium; ³ Department of Urology, S. Orsola-Malpighi University Hospital, Bologna, Italy; ⁴ USC Institute of Urology, University of Southern California, Los Angeles, CA, USA; ⁵ Department of Urology, Hospital Clínico San Carlos, Madrid, Spain; ⁶ Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; ⁷ Department of Urology, Valencian Institute of Oncology Foundation, Valencia, Spain; ⁸ Department of Urology and Nephrology, Virgen del Rocío University Hospital, Seville, Spain; ⁹ Department of Urology and Urological Surgery, Mannheim University Medical Center, Heidelberg University, Mannheim, Germany; ¹⁰ Department of Oncology, School of Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy, 11 Department of Surgery, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy